Teleca and Cypak develop world's first disposable electronic diabetes screening device for SmartSensor telemed

Malmo 10 November 2004SmartSensor telemed has commissioned Teleca to develop the world's first disposable diagnostic system for diabetes detection and monitoring. The solution is the first application-based on SmartSensor telemed's concept for disposable medical diagnostic instruments. The product is based on Cypak's innovative micro-electronics and a biosensor integrated in a disposable unit.

Advertisement

SmartSensor telemed has developed a concept that enables diabetes to be self-diagnosed at an early stage while there is still time to take preventative measures. With the help of Swedish innovation company Cypak's technology for embedding micro-electronics in paperboard, Teleca has produced the first working prototype, which consists of a paperboard-packaged blood biosensor for gathering, analysing and storing blood-test data.

The packaging also contains an electronic patient questionnaire. The data and the answers to the questionnaire are stored in a secure part of the packaging that is detached and sent to a hospital for analysis. The remaining part of the packaging is discarded. The technology can also be used to diagnose many other illnesses and a cholesterol system is also being developed. The low price of the finished products means they are also suitable for sale in emerging markets such as India, China and South America.

"To succeed we needed a partner who could help us develop our technology into a finished product in a cost-effective way, which is exactly what Teleca has managed to do. Together with its partner Cypak it has produced a very powerful solution", stated James Jackson, founder and chief technical officer of SmartSensor telemed.

"We're very pleased to be working with SmartSensor telemed because this company is at the forefront of a new and exciting area. Low-cost high-volume medical instruments is an expanding area that's providing us with more opportunities for business. We see a lot of potential for Cypak's innovative technology in this market", stated Magnus Bjorkqvist, MD for Teleca System Design.

Initially 1000 units will be manufactured for use in clinical tests on patients in England. Teleca and Cypak will also be developing an instrument for measuring cholesterol values. Teleca is an international IT services company focused on R&D that develops and integrates advanced software and information technology solutions. With in-depth expertise in the latest technology and profound industrial knowledge, Teleca helps technology- and software-intensive customers worldwide to strengthen their market position and shorten their time to market. The company has more than 3000 employees with operations in 15 countries in Asia, Europe and USA.

SmartSensor telemed is developing innovative solutions for disease detection and management, using a proprietary diagnostic device format linked to e-health care and telemedicine systems. The company is focused initially on diabetes and high cholesterol. SmartSensor telemed's mission is to increase access to health care for people at risk from major chronic diseases. The company is privately owned and based near Oxford, England.

Cypak is a Swedish technology innovator developing technology for embedding electronics into paper. Since its foundation in 1999, the company has created a wide range of applications to transform simple objects into secure data carriers, capable of capturing information about their environment and their usage. The company provides core components, integration services and licensing of patented technology. The company is privately held and is located in Stockholm.


Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]